Chromosomal microarray analysis-a routine clinical genetic test for patients with schizophrenia. (Q50568018)

15 March 2018

title

Chromosomal microarray analysis-a routine clinical genetic test for patients with schizophrenia. (English)

1 reference

15 March 2018

0 references

Kate Baker

1

0 references

author name string

Gregory Costain

series ordinal

2

1 reference

15 March 2018

Wai Lun Alan Fung

series ordinal

3

1 reference

15 March 2018

Anne S Bassett

series ordinal

4

1 reference

15 March 2018

publication date

5 September 2014

1 reference

15 March 2018

published in

The Lancet Psychiatry

1 reference

15 March 2018

volume

1

1 reference

15 March 2018

issue

5

1 reference

15 March 2018

page(s)

329-331

1 reference

15 March 2018

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

Genetic investigation for adults with intellectual disability: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

Practical guidelines for managing patients with 22q11.2 deletion syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

1q21.1 Microduplication expression in adults

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

Evaluating genetic counseling for individuals with schizophrenia in the molecular age

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

Is there a core neuropsychiatric phenotype in 22q11.2 deletion syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

De novo mutations in schizophrenia implicate synaptic networks

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2814%2970308-6

7 January 2021

10.1016/S2215-0366(14)70308-6

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018